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Abstract
Yaws, caused by Treponema pallidum ssp. pertenue, is reportedly endemic in Ghana.
Mass distribution of azithromycin is now the cornerstone of the WHO yaws eradication cam-
paign. Mass distribution of azithromycin at a lower target dose was previously undertaken in
two regions of Ghana for the control of trachoma. Ongoing reporting of yaws raises the pos-
sibility that resistance may have emerged in T. pallidum pertenue, or that alternative infec-
tions may be responsible for some of the reported cases. We conducted a cross-sectional
survey in thirty communities in two districts of Ghana where MDA for trachoma had previ-
ously been conducted. Children aged 5–17 years with ulcerative lesions compatible with
yaws were enrolled. Samples for treponemal serology and lesion PCR were collected from
all children. 90 children with 98 lesions were enrolled. Syphilis serology was negative in all
of them. PCR for T. pallidum ssp pertenue was negative in all children, but Haemophilus
ducreyiDNA was detected in 9 lesions. In these communities, previously treated for tracho-
ma, we found no evidence of ongoing transmission of yaws. H. ducreyiwas associated with
a proportion of skin lesions, but the majority of lesions remain unexplained. Integration of di-
agnostic testing into both pre and post-MDA surveillance systems is required to better in-
form yaws control programmes.
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Author Summary
Yaws is a chronic bacterial infection of the skin and bones that is endemic in Ghana. Since
2012, mass distribution of the antibiotic azithromycin has become the cornerstone of the
WHO yaws eradication campaign. Accurate surveillance data are necessary to guide deci-
sions about where MDA is required. Many national surveillance systems report only clini-
cal cases without laboratory confirmation, which may lead to misdiagnosis. Mass
distribution of azithromycin, at a lower dose than is used for yaws, is also used in the con-
trol of the eye disease trachoma. Between 2001 and 2008, two regions of Ghana undertook
distribution of azithromycin to eliminate trachoma. These regions still report cases of
yaws, and it is unclear if these are due to drug resistant yaws or other causes. We con-
ducted a survey of patients with skin ulcers that looked like yaws in one of these regions of
Ghana. Blood tests for yaws were negative in all the individuals examined and molecular
testing of the ulcers did not show evidence of yaws caused by drug resistant Treponema
pallidum ssp. pertenue. Our data suggest that previous treatment for trachoma may have
also treated yaws in these districts. These findings highlight the need for yaws control pro-
grammes to integrate diagnostic testing into surveillance.
Introduction
Yaws is a re-emerging endemic treponemal infection caused by Treponema pallidum ssp. perte-
nue [1]. Early disease is characterised by papillomatous and ulcerative skin lesions, whilst late
stage disease is characterised by skin lesions, bony involvement, and rarely progression to de-
structive lesions of the nasopharynx. Azithromycin (30mg/kg, maximum dose 2g) has recently
been shown to be effective in the treatment of yaws and is now central to WHO’s yaws eradica-
tion strategy [2, 3]. Azithromycin is also key to the “SAFE” strategy for trachoma elimination.
The target dose used in trachoma mass treatment (20mg/kg, maximum dose 1g) is lower than
that demonstrated to be effective against yaws [4] although the delivered dose is frequently
higher when a height based dosing strategy is used [5]. Although resistance has yet to be docu-
mented in yaws, azithromycin resistance has emerged in other treponemal infections, notably
syphilis [6–9]. The development of drug resistant T. pallidum ssp pertenue would have signifi-
cant implications for yaws eradication ambitions.
In the 1950s–60s and 1980s, two large yaws control programmes using penicillin were con-
ducted in Ghana, successfully reducing the burden of the disease, but yaws has subsequently
re-emerged throughout the country and Ghana remains a major focus of transmission in Af-
rica. Over 20,000 clinical cases were reported there in 2010 [10]. Ghana undertook azithromy-
cin mass drug administration for the control of trachoma between 2001 and 2008 in the
Northern and Upper West regions of the country [11]. Both regions continue to report cases of
yaws through the national surveillance system (Fig. 1).
The epidemiology of yaws has been further complicated by the discovery that Haemophilus
ducreyi, the causative agent of the ulcerative sexually transmitted disease chancroid, is a com-
mon cause of non-genital skin lesions in several countries where yaws is endemic [12, 13]. This
makes the accuracy of surveillance data based on clinical case detection alone, without serologi-
cal or molecular diagnostics, uncertain. A wide range of other organisms may cause ulcerative
skin lesions, includingMycobacterium ulcerans, the causative agent of Buruli Ulcer, which is
endemic in Ghana.
There is an urgent need to obtain accurate data on the epidemiology of yaws to guide
disease eradication efforts. Ongoing reporting of yaws in Ghana, despite several rounds of
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azithromycin MDA, raises the possibility that resistance may have emerged in T. pallidum ssp.
pertenue or that alternative causes may be responsible for some or all of the cases reported in
some regions of the country. As current information suggests that Ghana is a major focus of
yaws worldwide, either finding would have implications for the WHO yaws
eradication campaign.
We conducted a yaws survey in two districts of Ghana in which MDA for trachoma was pre-
viously undertaken, and from which cases of yaws are still reported via the national surveillance
system. We hypothesised that bothH. ducreyi and azithromycin-resistant strains of T. palli-
dum ssp pertenue would be responsible for clinical cases of yaws seen in these districts.
Figure 1. Map of Ghana showing number of yaws cases reported by the national surveillance system
in 2012 and the regions where azithromycin mass drug administration for trachoma was conducted
between 2001 and 2008.
doi:10.1371/journal.pntd.0003496.g001
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Methods
Survey Design
We conducted a cross-sectional observational survey of moist ulcers suspicious for yaws in two
post-azithromycin-MDA districts of northern Ghana, in the rainy season of June–July 2014.
Yendi and Savelugu-Nanton undertook four and six annual rounds of azithromycin MDA for
elimination of blinding trachoma, respectively, between 2001 and 2007 and both still report
cases of yaws to the Regional Health Directorate.
Patient Recruitment
In each community visited, children attending school (aged 5 to 17 years) were screened for
the presence of moist ulcers suspicious for yaws according to the WHO yaws pictorial guide
[14]. Children with other features of yaws were not enrolled, unless they also had a moist or ex-
udative ulcer from which a lesion swab could be obtained.
Study Procedures
For each participant we conducted a standardised interview including information about dura-
tion and location of skin lesions and presence or absence of bone symptoms compatible with
secondary yaws. Children then underwent a standardised examination including examination
of all skin lesions and for evidence of secondary yaws. For each ulcer, an impression of the
shape of each moist ulcer was recorded, followed by measurement of its longest and shortest
axes. Ulcers were classified as acute if they had been present 28 days or less, and as chronic if
they had been present for longer. Ulcers were classified as deep if there was subcutaneous in-
volvement; and tender if palpation prompted an involuntary expression of pain. Slough or
granulation in the ulcer base and induration of ulcer edges were also recorded [13]. We system-
atically examined patients for the presence of regional lymphadenopathy.
A serum sample was collected from each patient for syphilis serological testing. Each exuda-
tive ulcer was swabbed with a single sterile swab. The swab was then placed onto an FTA Elute
Micro Card (GE Healthcare, Buckinghamshire, UK) using three side-to-side motions, whilst
pressing down firmly. Cards were placed inside separate re-sealable plastic packets with a sa-
chet of desiccant. The ulcer was dressed to deter flies. Following completion of study proce-
dures each participant was weighed, and the appropriate single oral dose of azithromycin
offered for empirical treatment of yaws.
Laboratory Testing
Serum samples were stored at –20°C and transferred to Komfo Anokye Teaching Hospital
(KATH), Kumasi, where they were thawed and tested using the Treponema pallidum particle
agglutination (TPPA)(Mast Diagnostics, Merseyside, UK) and qualitative rapid plasma reagin
(RPR) tests (Deben Diagnostics, Ipswich, UK). Samples that were positive on qualitative RPR
testing were titrated out to obtain a quantitative RPR. Serology was considered positive for
yaws if the TPPA was positive and the RPR titre was1:8. All serological tests were conducted
in duplicate. 10% of serum samples, selected at random, were retested by an independent labo-
ratory scientist for quality control purposes.
All swab samples were transferred to the Centers for Disease Control and Prevention (CDC)
where DNA was extracted and subjected to real-time PCR for the detection of T. palladium ssp.
pertenue, as previously described [15]. If any samples tested positive for T. pallidum a second
real-time PCR for the A2058G and A2059G mutations associated with macrolide resistance
[16] was ready to be applied. Regardless of the result of T. pallidum ssp. pertenue testing, all
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samples were additionally tested with a second multiplex PCR forH. ducreyi andM. ulcerans
DNA, using previously validated targets [17, 18].
Statistical Analysis
We compared the clinical features and serological results of the children with yaws, H. ducreyi,
and dual infections using Fisher’s exact test. All analyses were performed using Stata 13.1 (Sta-
tacorp, Texas).
Ethics
Informed written consent was obtained from each child’s parent or guardian, and assent was
gained from children by staff fluent in local dialects. The research protocol was approved by the
London School of Hygiene & Tropical Medicine (LSHTM) (ref. no. 8202), the Kwame Nkru-
mah University of Science and Technology (KNUST) Committee on Human Research, Publica-
tion and Ethics (ref. CHRPE/AP/225/14), and the CDC’s National Center for HIV/AIDS, viral
hepatitis, STD and TB prevention (NCHHSTP) Associate Director for Laboratory Science (ref.
no. 6634).
Results
Approximately 3,000 children from thirty communities were screened for inclusion in the
study. 92 children (with a total of 100 moist ulcers) from a total of thirty communities were en-
rolled in the study. Two children (with one ulcer each) were later found to be ineligible (the
first was over 18 years, and the second was from a community that did not undergo azithromy-
cin MDA for trachoma), and were excluded from the results, leaving 90 children with a total of
98 moist ulcers. Many children had evidence of other skin problems but there was no evidence
of typical papillomatous, palmar-plantar or macular lesions of primary or secondary yaws. The
median age of enrolled children was 10 years (IQR 8 to 12 years), and 68 subjects (76%) were
male. Thirty-seven children (41%) had not been born or were aged less than 1 at the time
MDA was completed in their district (Table 1).
Table 1. Baseline characteristics of study participants.
Overall
n = 90
Yendi District n = 46
(51%)
Savlugu-Nanton District n = 44
(49%)
Male sex 68 (76%) 33 (72%) 35 (83%)
Age (years)
5–8 28 (30.4%) 12 (26%) 16 (37%)
9–12 50 (55.6%) 27 (59%) 23 (52%)
13–17 12 (14%) 7 (15%) 5 (11%)
Eligible for MDA*
No rounds of MDA* 37 (41%) 9 (20%) 28 (64%)
At least 1 round of
MDA*
53 (59%) 37 (80%) 16 (36%)
All rounds of MDA* 19 (21%) 16 (35%) 3 (7%)
*MDA was conducted in Yendi District between 2004 and 2007. MDA was conducted in Savelugu-Nanton
district between 2001–2004. Individuals were considered eligible for at least 1 round of MDA if they were
aged 1 or over the ﬁnal year MDA was conducted in their district. Individuals were considered eligible for all
rounds of MDA if they were aged 1 or over in the ﬁrst year MDA was conducted in their district.
doi:10.1371/journal.pntd.0003496.t001
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The majority of ulcers sampled, 91/98 (93%), were on the lower legs, and 54/98 (55%) were
painful. There was a balance of acute (53/98, 54%) and chronic lesions (45/98, 46%). Many par-
ticipants reported applying local topical treatments to skin lesions, including gentian violet
paint, animal faeces or the contents of antibiotic capsules known as” topaya” or “bullets”
(Fig. 2). Bone or joint symptoms and signs were noted in 54/92 individuals (59%). Although
mild lymphadenopathy was common, no participant had clinically significant
regional lymphadenopathy.
Serology for treponemal infections (both TPPA and qualitative RPR) was non-reactive in all
individuals. Quantitative RPR was not performed, as no samples were positive with qualitative
RPR. Using real-time PCR, T. p. pertenue DNA was not detectable in any lesion sample.
H. ducreyi DNA was detected in 9/98 (9.2%) ulcers (from eight children). Two children in-
fected with H. ducreyi had two moist ulcers: in one caseH. ducreyi DNA was detected in only
one ulcer, and in the other case, both ulcers were positive for H. ducreyi DNA. PCR was nega-
tive for all three pathogens in swabs from the majority (89/98, 91%) of ulcers. There was no sig-
nificant difference in the clinical characteristics ofH. ducreyi positive and H. ducreyi negative
lesions (Table 2).
Discussion
In this study conducted in the Northern Region of Ghana we found no evidence of active or la-
tent yaws. All patients in this study had negative treponemal and non-treponemal serology.
The fact that treponemal-specific serology was negative indicates that these individuals have
never been infected with yaws. Both of the districts selected for this study had completed sever-
al rounds of azithromycin MDA for trachoma in the preceding decade. It is plausible that
MDA for trachoma interrupted transmission of yaws resulting in its elimination in these dis-
tricts and that these children, of whom about forty-percent never received MDA, have there-
fore never been exposed to yaws.
The original intention of this study had been to identify azithromycin resistant strains of
T. pallidum ssp pertenue that may have emerged following MDA, given that a lower target dose
of azithromycin is used in trachoma control programmes than is now recommended in yaws
control programmes. The absence of any drug resistant strains of T. pallidum pertenue in an
Figure 2. Ulcerative lesions to which with local treatment have been applied. a) Lesion treated with gentian violet paint. b) Lesion treated with animal
excrement. c) Lesion treated with ‘topaya’—the content of an antibiotic capsule.
doi:10.1371/journal.pntd.0003496.g002
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area with repeated exposure to lower dose azithromycin is encouraging for other settings
where trachoma and yaws are co-endemic and may reflect the higher target dose of azithromy-
cin that is normally achieved with a height based dosing strategy. An alternative possibility is
that these regions were never endemic for yaws. Exploring this hypothesis would require large
numbers of historic specimens and was beyond the scope of the current study.
Our study highlights the poor specificity of clinical case reporting and the urgent need to in-
tegrate serology into clinical surveillance systems. Yaws cases continue to be reported from
both the districts we visited but our results show that these cases are extremely unlikely to rep-
resent yaws. A rapid diagnostic test for yaws has shown value both in community surveillance
[19] and as a confirmatory test in clinically suspected cases [20] and our data strengthen the
case for this test to be made available to national yaws programmes as soon as possible.
Results of PCR testing add further to the growing evidence that H. ducreyi is a cause of non-
genital ulcerative skin lesions in children. This study is the first to report on the impact of test-
ing multiple skin lesions from the same individual. Of those with multiple tested lesions, we
identified some whose PCR results were concordant between lesions and others where PCR re-
sults were discordant between lesions: only testing one lesion may result in the false assump-
tion that all of a patient’s lesions have the same aetiology. Whilst azithromycin has been shown
to be effective at treating non-genital H. ducreyi in experimental models [21], it will be impor-
tant to develop tools to monitor for the emergence of drug resistance in real-world settings.
Of equal significance is the large proportion of lesions for which no aetiological agent was
identified. It is likely that many lesions were non-infectious, for example due to trauma or fly
bites. Common bacterial infections such as Staphylococcus aureusmay also have been responsi-
ble. Further study, including longitudinal data, will be needed to assess this question in more
detail. Understanding the aetiology and epidemiology of non-yaws skin lesions is important
for maintaining community engagement with mass drug administration programmes for the
eradication of yaws.
Our study has a number of limitations. Most notably we only enrolled individuals with ul-
cerative lesions. It is possible that if we had also enrolled children with other skin lesions com-
patible with yaws, we may have identified some seropositive subjects. The negative TPPA
testing in all individuals in our study however, suggests there is minimal transmission of trepo-
nemal diseases in children in this community. Secondly, we only tested skin lesions for a small
number of aetiological agents, which limits our ability to fully characterise the cause of skin le-
sions in this community. Finally, whilst we know which districts were treated during the
Table 2. Clinical Features of Ulcerative Lesions.
Lesions from which Haemophilus
ducreyi DNA detected (n = 9)
Lesions from which Haemophilus ducreyi
DNA not detected (n = 89)
Odds Ratio p
Male sex 7 (78%) 69 (78%) 1.01 (0.19–5.32) 0.9864
Age (median (inter-quartile
range))
10 (8–11) 10 (8–12) N/A 0.7466
Duration (mean weeks
(inter-quartile range))
4.3 (2–12.9) 3 (1.4–4.3) N/A 0.4831
Deep Ulcer 5 (56%) 45 (51%) 1.22 (0.31–4.89) 0.7763
Round Shape 3 (33%) 16 (18%) 2.28 (0.51–10.27) 0.2692
Tender Ulcer 9 (100%) 85(96%) N/A 0.5182
Indurated Edges 5 (56%) 42 (47%) 1.40 (0.35–5.60) 0.6339
Lesion site in lower limb 9 (100%) 87 (98%) N/A 0.6512
doi:10.1371/journal.pntd.0003496.t002
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trachoma control programme and that an overall programmatic coverage of 93.9% was re-
ported [22], there are limited data on the actual coverage achieved in the specific communities
we visited in this study.
In summary, we found no evidence of ongoing transmission of yaws in two districts of
Ghana, which had previously received MDA for trachoma. As in other countries, it is clear that
H. ducreyi is responsible for clinically similar skin lesions but the majority of lesions remain
unexplained. There is an urgent need to integrate serological testing into surveillance to better
inform national reporting data and yaws control programmes.
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